Skip to Main Content

Paper Details

Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases.
EBioMedicine
14
2023
FinnGen, TYK2, TYK2 gene, arthritis, autoimmune diseases, hypothyroidism, plaque psoriasis, prostate and breast cancer, psoriasis, rheumatoid, rs34536443, systemic lupus erythematosus, tissue
Author NameAffiliation
Xia ShenUsher Institute, University of Edinburgh, UK Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University
James F WilsonUsher Institute, University of Edinburgh
  • 1 - 2

Datasets

Release 1.2